Literature DB >> 11731144

Sensitivity of Shiga toxin-producing Escherichia coli (STEC) strains for colicins under different experimental conditions.

B J Jordi1, K Boutaga, C M van Heeswijk, F van Knapen, L J Lipman.   

Abstract

Twenty Escherichia coli strains producing well-characterised colicins were tested for their inhibitory activity against five Shiga toxin-producing E. coli (STEC) strains using different media under aerobic and anaerobic conditions. The five STEC strains used were of serotype O26, O111, O128, O145 and O157:H7 which are frequently isolated serotypes associated with disease in humans. The main route of infection for humans is through the eating of badly cooked or handled beef. The major reservoir for STEC strains in cattle is the rumen. To mimic the situation in the rumen of cattle, overlay assays were also performed under anaerobic conditions in the presence of 30% rumen fluid. Colicins E1, E4, E8-J, K and S4 are most active against STEC strains under anaerobic conditions in the absence or presence of rumen fluid. These colicins will be used in future experiments with the aim to eradicate the presence of STEC in cattle.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731144     DOI: 10.1111/j.1574-6968.2001.tb10906.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  12 in total

1.  Smarter arrow now available in the food safety quiver.

Authors:  Todd R Callaway; Trisha G Sheridan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-23       Impact factor: 11.205

2.  Prevalence of ColE1-like plasmids and colicin K production among uropathogenic Escherichia coli strains and quantification of inhibitory activity of colicin K.

Authors:  Matija Rijavec; Maruska Budic; Peter Mrak; Manica Müller-Premru; Zdravko Podlesek; Darja Zgur-Bertok
Journal:  Appl Environ Microbiol       Date:  2006-11-22       Impact factor: 4.792

3.  Accumulation of single-stranded DNA in Escherichia coli carrying the colicin plasmid pColE3-CA38.

Authors:  Magali Morales; Hedieh Attai; Kimberly Troy; David Bermudes
Journal:  Plasmid       Date:  2014-11-05       Impact factor: 3.466

4.  Prevalence of enteric bacteria that inhibit growth of enterohaemorrhagic Escherichia coli O157 in humans.

Authors:  H Toshima; M Hachio; Y Ikemoto; J Ogasawara; A Hase; K Takahashi; H Masaki; Y Nishikawa
Journal:  Epidemiol Infect       Date:  2006-06-02       Impact factor: 2.451

5.  Inhibitory activities of colicins against Escherichia coli strains responsible for postweaning diarrhea and edema disease in swine.

Authors:  Chad H Stahl; Todd R Callaway; Leslie M Lincoln; Steven M Lonergan; Kenneth J Genovese
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

6.  Dietary inclusion of colicin e1 is effective in preventing postweaning diarrhea caused by F18-positive Escherichia coli in pigs.

Authors:  S A Cutler; S M Lonergan; N Cornick; A K Johnson; C H Stahl
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

7.  Enhancement of Shiga toxin production in enterohemorrhagic Escherichia coli serotype O157:H7 by DNase colicins.

Authors:  Hirono Toshima; Ayana Yoshimura; Kentaro Arikawa; Ayumi Hidaka; Jun Ogasawara; Atsushi Hase; Haruhiko Masaki; Yoshikazu Nishikawa
Journal:  Appl Environ Microbiol       Date:  2007-10-12       Impact factor: 4.792

8.  Escherichia coli bacteriocins: antimicrobial efficacy and prevalence among isolates from patients with bacteraemia.

Authors:  Maruška Budič; Matija Rijavec; Ziva Petkovšek; Darja Zgur-Bertok
Journal:  PLoS One       Date:  2011-12-19       Impact factor: 3.240

Review 9.  Antibacterial activities of bacteriocins: application in foods and pharmaceuticals.

Authors:  Shih-Chun Yang; Chih-Hung Lin; Calvin T Sung; Jia-You Fang
Journal:  Front Microbiol       Date:  2014-05-26       Impact factor: 5.640

10.  Bacteriocins - exploring alternatives to antibiotics in mastitis treatment.

Authors:  Reneé Pieterse; Svetoslav D Todorov
Journal:  Braz J Microbiol       Date:  2010-09-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.